CD2 and neoplasm: Compared to pretreatment samples, T cells from TCE-treated patients exhibited reduced cytokine production following stimulation with anti-CD2/3/28 antibodies or viral peptides and reduced activation/tumor lysis in tumor-T cocultures (Figure 1, G–J, and Supplemental Figure 3, E–H).